Executive record

Joseph E. Payne

Director at Arcturus Therapeutics Holdings Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:joseph-e-payneVersion: public-0As of: 2026-09-29

Not yet claimed9 published Claims3 sources
  • Director

Key Claims

Biography

President and Chief Executive Officer with over 20 years of drug discovery experience at major pharmaceutical companies including Merck, Bristol-Myers Squibb, and others. Expertise in targeted RNA medicines utilizing lipid-mediated delivery technologies with over 40 publications and patents.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: President and Chief Executive Officer · Organization not publishedARCT DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ARCT DEF 14A director slate

    sec filing · Source published: Apr 25, 2025 · Retrieved: May 15, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Board · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Arcturus Therapeutics Holdings Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Apr 25, 2025 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at Arcturus Therapeutics Holdings Inc. · Claim reviewed: May 15, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Arcturus Therapeutics Holdings Inc. · Claim reviewed: May 15, 2026